Scarica l'app Stockscreener
0.428
0.94%
0.004
Silo Pharma Inc Borsa (SILO) Ultime notizie
Silo Pharma Inc. (SILO) Rallies 3.99% as Biotech Sentiment Improves — Key Levels in FocusHigh Yield Stocks - thelegaladvocate.com
Silo Pharma Inc. (SILO) Q4 2023 Earnings: Widening Losses as Pre-Revenue Biotech Focuses on Pipeline ProgressProfit Margin Analysis - Newser
SILO Q4 2023 Earnings: Biotech Misses EPS Estimates as Pre‑Revenue Phase ContinuesCrowd Stock Picks - Newser
SILO Stock Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
Silo Pharma Inc. (SILO) Edges Higher as Shares Test Key ResistanceAggressive Growth Picks - Newser
Silo Pharma (SILO) Q4 2023 Results Disappoint: What Investors Should KnowRevenue Miss Report - thelegaladvocate.com
Silo Pharma (SILO) Q4 2023 Earnings: Miss Sparks ConcernTrending Entry Points - Newser
Silo Pharma (SILO) Stock Analysis: Falls -3.79%, Watching $0.35 2026-05-19NHNL Ratio - thelegaladvocate.com
Silo Pharma, Inc. (SILO) Q1 2026 10-Q: Financials, Crypto Asset Holdings, and Business Developments - Minichart
Silo Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Silo Pharma (NASDAQ: SILO) Q1 loss widens as R&D and crypto costs rise - Stock Titan
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative - citybuzz -
Silo Pharma files patent for ibogaine-based TBI treatment By Investing.com - Investing.com Australia
Silo Pharma files patent for ibogaine-based TBI treatment - Investing.com
With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - ChartMill
Silo Pharma files patent for ibogaine-based therapy targeting traumatic brain injury. - Pluang
Silo Pharma rallies after securing key patent allowance - MSN
SILO Stock Price, Quote & Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
SILO Silo Pharma reports wider-than-expected Q4 2023 loss, shares dip 1.62% amid weak investor sentiment.High Attention Stocks - Newser
Silo Pharma’S Ptsd Program Advances As FDA Fast-Tracks Psychedelic Therapies For Ptsd - TradingView
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - GlobeNewswire
Washington speeds psychedelic PTSD work as Silo spotlights program - Stock Titan
Why did SILO stock soar 85% today? - MSN
Levi Strauss, Greenbrier and 3 stocks to watch heading into Tuesday - MSN
SILO Silo Pharma rises 5.57 percent despite reporting a wider than expected Q4 2023 per share loss.Gross Margin - Newser
CMND stock set for biggest intraday gains in over three years — here’s why retail is eyeing further upside - MSN
SILO Price Today: Silo Pharma, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAxe Compute (NASDAQ:AGPU), Akanda (NASDAQ - Benzinga
Silo Pharma launches AI subsidiary, advances PTSD drug program By Investing.com - Investing.com India
AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Into AI With Qwikagents Asset Acquisition - FinancialContent
Silo Pharma Inc. posts 76.5% EPS miss with no reported revenueDividend Initiation - Cổng thông tin điện tử tỉnh Tây Ninh
Is Southern (SOJD) stock recovering momentum | Q3 2000: Profit SurprisesDecline Phase - Xã Thanh Hà
Silo Pharma launches AI subsidiary, advances PTSD drug program - Investing.com
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents - The Manila Times
A biotech advancing a PTSD drug just bought an AI agent platform - Stock Titan
Silo Pharma, Inc. acquired Assets of Qwikagents.ai. - marketscreener.com
Silo Pharma highlights PTSD treatment program amid policy shift By Investing.com - Investing.com India
Silo Pharma highlights PTSD drug program amid policy shift By Investing.com - Investing.com India
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics - marketscreener.com
Silo Pharma (SILO) Stock Payout Ratio (Momentum Building) 2026-04-20Buy Signals - Cổng thông tin điện tử tỉnh Lào Cai
Silo Pharma highlights PTSD drug program amid policy shift - Investing.com
Silo Pharma highlights PTSD treatment program amid policy shift - Investing.com
Silo Pharma Positioned to Advance Treatment Targeting PTSD - GlobeNewswire
0.37%
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):